News 
Market Data 
Discover
Replies to post #146397 on Kraig Biocraft Laboratories Inc (KBLB)
11/30/18 6:10 PM
CHIMERIC SPIDER SILK AND USES THEREOF
Family Patent
No. Family No. Country(code) Country Type
1 AU2011314072 AU Australia A1
2 AU2011314072 AU Australia B2
3 CA2812791 CA Canada A1
4 CN103261231 CN China A
5 CN107190017 CN China A
6 EP02621957 EP European Patent Office (EPO) A2
7 JP26502140 JP Japan A
8 JP29127309 JP Japan A
9 US20150322121 US United States of America A1
10 US20130212718 US United States of America A1
11 US20150322122 US United States of America A1
12 WO2012050919 WO World Intellectual Property Organization (WIPO) (International Bureau of) A2
13 WO2012050919 WO World Intellectual Property Organization (WIPO) (International Bureau of) A3
14 KR1020140095010 KR Republic of Korea A
iKRAIG BIOCRAFT LABORATORIES FILES FOR PATENT PROTECTION OF DRAGON SILK
LANSING, Mich., – August 19, 2015 – Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of advanced spider silk based fibers, announced that it, with the University of Notre Dame, filed two additional patents to strengthen its intellectual property protection surrounding its transgenic silkworms and spider silk technologies.
These patent applications are designed to protect the creation of the Kraig Labs transgenic silkworms and the resultant chimeric spider silk. The Company currently has open patent actions in 10 countries, including key silk producer and consumer nations.
CHIMERIC SPIDER SILK AND USES THEREOF-KIPRIS
Application No.10-2018-7034773
Details Unexam. Full Text Administrative
Administrative Actions
No. Document Title Receipt/Delivery Date Status Receipt/Delivery No.
1 [Divisional Application(International Application)] Patent Application
2018.11.30 Accepted
112018119872191
2 Notification of Ex officio Correction
2018.12.03 Completion of Transmission
152018018893017
